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Hereditary spherocytosis is a clinically heterogeneous, geneti-
cally determined red blood cell membrane disorder resulting in
hemolytic anemia. A deficiency of spectrin, the largest and most
abundant structural protein of the erythrocyte membrane skel-
eton, results in the formation of spherocytes which lack the
strength, durability, and flexibility to withstand the stresses of
the circulation. Clinical manifestations of the disease are pri-
marily dependent on the severity of hemolysis, which additionally
results in an increased incidence of pigment gallstones. The like-
lihood of cholelithiasis is directly related to patient age and is
uncommon before 10 years of age. Splenectomy is indicated in
virtually every patient. When the disease is diagnosed in early
childhood, the risk of overwhelming postsplenectomy sepsis
makes it advisable to delay splenectomy until after 6 years of
age if possible. At the time of splenectomy, it is important to
identify and remove any accessory spleens. If gallstones are
present, cholecystectomy should be performed. Although sphe-
rocytosis persists following splenectomy, hemolysis is alleviated
and clinical cure of the anemia is achieved for most patients.
Patients with recessively inherited spherocytosis are exceptions.
Although they are significantly benefited by splenectomy, their
anemia is not completely corrected. Splenectomy reduces he-
molysis in all patients and thereby decreases the risk for devel-
opment of pigment gallstones. Excision of an enlarged spleen
removes the danger of traumatic rupture.
H' 'EREDITARY SPHEROCYTOSIS (HS) is a clinically
heterogeneous, genetically determined red
blood cell membrane disorder resulting in he-
molytic anemia. HS has an incidence in the United States
of 2-4 cases per 10,000 population.",2 The pattern of in-
herntance is typically autosomal dominant with other af-
fected family members being found in approximately 75%
of cases. Sporadic cases, presumably occurring as new
mutations, and rare cases presenting in an autosomal re-
cessive manner account for the remainder.3
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The membrane defect resulting in the shortened sur-
vival of erythrocytes in HS has been found to be a defi-
ciency in spectrin, the largest and most abundant struc-
tural protein of the red cell membrane skeleton.3'4
Thought to be responsible for the shape, strength, and
reversible deformability of the red cell, the membrane
skeleton provides the flexibility and durability necessary
for the erythrocyte to withstand the turbulence, pressures,
and shearing stresses of the circulation.3-5 Spectrin defi-
ciency in the membrane skeleton leads to a gradual loss
of red cell surface area so that the erythrocyte becomes
spherical instead ofremaining a biconcave disc. Incapable
ofdeforming adequately to traverse the splenic microcir-
culation, the relatively rigid spherocytes are trapped in
the splenic red pulp and are destroyed.
Clinical manifestations of HS are variable and are re-
lated to the severity of hemolysis. Rarely, the disease can
be so severe that repeated blood transfusions are necessary
in infancy and splenectomy is required early in childhood.
Alternatively, the anemia can be so mild as to go unno-
ticed, with the diagnosis being established late in life after
the development ofsymptomatic cholelithiasis. An aplas-
tic crisis, usually precipitated by a viral illness, or a he-
molytic crisis may produce a rapidly worsening anemia
that may be life threatening. Most patients have a minimal
increase in serum bilirubin as a direct consequence of
active, ongoing red cell destruction. Intermittent episodes
of jaundice may occur, often in association with a viral
illness. As a result ofthe chronic hemolysis, patients with
HS have an increased incidence of pigment gallstones.
Splenomegaly of a mild to moderate degree is a charac-
teristic physical finding. The diagnosis can be established
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by demonstration of spherocytes in the peripheral blood
smear, reticulocytosis, an increased osmotic fragility of
fresh and incubated red cells and a negative direct
Coombs' test. Whenever possible, studies offamily mem-
bers also should be performed.
This article cites our experience with HS over the past
15 years and reviews the clinical presentation, diagnosis,
and management of this disease. Additionally, the im-
portant new diagnostic role of spectrin analysis will be
illustrated in several of our patients having HS on the
basis of presumed autosomal recessive inheritance.3
Case Reports
Patient 1
As a full-term newborn, this 5-year-old white female developed jaundice
with a peak serum bilirubin of 19.6 mg/dl. At 4 weeks of age she was
severely anemic with a hematocrit of 21% and a reticulocyte count of
8.4%. Her red cells were spherocytic, and a direct Coombs' test was
negative. Incubated erythrocytes demonstrated increased osmotic fragility.
Hereditary spherocytosis existed in the mother and maternal grand-
mother. Throughout early childhood, her disease remained well com-
pensated with her hematocrit ranging from 28 to 34% and reticulocytes
ranging from 7. 1 to 12. 1%. Transient scleral icterus and mild worsening
ofanemia occurred on several occasions with a viral illness. Intermittent
episodes of upper abdominal discomfort were felt possibly to represent
biliary colic. The spleen was easily palpable. An ultrasound examination
demonstrated sludge within the gallbladder. Splenectomy was performed,
removing a 220 g spleen and two accessory spleens measuring 1.0 and
1.5 cm in diameter. Small calculi were palpable within an otherwise
normal gallbladder. A cholecystectomy was performed with the gall-
bladder containing numerous 1-2 mm pigment stones. Her postoperative
course was uncomplicated, and she was discharged on the fifth postop-
erative day. Over the subsequent 2 years, she has remained well with a
normal hematocrit and reticulocyte count.
Comment
This patient demonstrates the typical form ofhereditary
spherocytosis which follows an autosomal dominant pat-
tern of inheritance. Splenectomy in this type of patient
alleviates hemolysis and achieves clinical cure ofthe ane-
mia although spherocytosis persists.
Patient 2
This 11-year-old white female was found to have a hemoglobin of 4.5
g/dl when she was 3 months old. Her red cells were spherocytic, and
a Coombs' test was negative. Incubated erythrocytes demonstrated in-
creased osmotic fragility. There was no family history ofHS. Bone marrow
aspiration showed extreme erythroid hyperplasia. She received packed
red cells on three occasions, and after 6 months of age her hematocrit
remained about 12% with 15 to 35% reticulocytes without further trans-
fusions. At 17 months ofage, she was icteric, and her spleen was palpable
at the level of the umbilicus. A chest radiograph showed borderline car-
diomegaly. The hemoglobin was 4.3 g/dl. Splenectomy was performed,
removing a 365 g spleen, which showed marked congestion with he-
mosiderin deposition. A 0.5 cm accessory spleen also was excised. Fol-
lowing an uncomplicated recovery, she was discharged on the seventh
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postoperative day. Her hemoglobin rose after splenectomy and during
the subsequent 91/2 years has remained at 11 to 12 g/dl with an associated
reticulocyte count of 5 to 6%. Spherocytosis continues to be remarkably
prominent.
Patient 3
This 8-year-old sister of Patient 2 weighed 2530 g and was noted to
have spherocytosis when she was born 2 weeks prematurely. Serum bil-
irubin rose to 17 g/dl, and she required ultraviolet light and exchange
transfusion. Over the next 10 weeks, her hematocrit steadily declined to
7%. She received red cell transfusions every 4 to 6 weeks thereafter until
splenectomy was performed at age 7 months. The spleen was palpable
below the left costal margin and weighed 80 g. A 1.0 cm accessory spleen
also was excised. She recovered from the operation without complication
and was discharged on the fifth postoperative day. Over the subsequent
71/2 years, her hemoglobin has been 11 to 12 g/dl and reticulocytes have
numbered 6 to 7%. Red cell morphology has remained identical to that
of her older sister.
Comment
Further evaluations of Patients 2 and 3 were carried
out at 7 and 5 years of age, respectively.3 Their red cell
membrane ghosts were found to be at least 50% deficient
in spectrin when analyzed by sodium dodecyl sulfate
polyacrylamide-gel electrophoresis (SDS-PAGE), and the
spectrin deficiency also was detected when whole red cell
lysates were analyzed by radioimmunoassay.36 Their par-
ents, who were distantly related (fourth cousins), were
clinically normal and were found to have normal amounts
of red cell membrane spectrin.3 All grandparents, uncles,
and aunts had normal red cells. There was no familial
history of blood disorders.
Patients 2 and 3 demonstrate a severe form ofhereditary
spherocytosis that results from an inadequate amount of
spectrin in the membrane skeleton. The severity of the
disorder required early splenectomy, which produced
striking clinical improvement but incomplete reliefofthe
hemolytic anemia. The mode of inheritance was probably
autosomal recessive.3
Patient 4
This full-term white male neonate wasjaundiced at birth with umbilical
cord blood having a serum direct bilirubin of 9 mg/dl. At 3 days of age,
his bilirubin had risen to 61 mg/dl. His hematocrit was 21% with a
reticulocyte count of 16.5%. Subsequently, the severity ofanemia required
red cell transfusions every 3 to 6 weeks to maintain the hematocrit above
15%. His parents and two older siblings were healthy with no history of
anemia orjaundice, and there was no familial history ofblood disorders.
Hyperbilirubinemia gradually cleared. Extensive investigation of his
anemia, which included a direct Coombs' test, incubated osmotic fragility,
hemoglobin electrophoresis, and comprehensive analysis of red cell en-
zymes, revealed normal findings. Bone marrow aspiration disclosed in-
tense erythroid hyperplasia. Analysis of red cell membrane ghosts dem-
onstrated severe spectrin deficiency.6'7 At 14 months of age, a palpably
enlarged spleen weighing 130 g and a 2 mm accessory spleen were excised.
Recovery was uncomplicated, and over the subsequent 15 months his
hemoglobin has ranged from 10-13 g/dl with 2 to 5% reticulocytes.
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TABLE 1. Clinical Data in Patients With Hereditary Spherocytosis
Transfusion Average
Age Number of Patients Palpable Dependent Splenic Weight, Accessory
(Years) (Male, Female) Spleen Anemia grams (Range) Spleen Cholelithiasis
0-4 5 (3, 2) 5 4 185(80-365) 4 0
5-9 7 (4, 3) 7 0 250(100-600) 4 2
10-14 3 (1, 2) 2 0 590(260-1025) 0 1
15-19 1 (0, 1) 1 0 700(700) 1 0
20+ 7 (5, 2) 7 0 630 (380-800) 0 3
Total 4
23 (13, 10) 22 (96%) 9 (39%) 6 (26%)
Comment
Because ofthe severity of this patient's hemolytic ane-
mia, transfused red cells constituted the majority of his
circulating erythrocytes and resulted in the incubated os-
motic fragility being normal. A similar explanation is
postulated for the presence ofnormal amounts ofred cell
membrane spectrin in normal transfused cells in this pa-
tient but a deficiency of spectrin in his microspherocytes
and reticulocytes separated from older transfused cells by
lowspeed centrifugation.7
The absence of a familial history of hereditary sphero-
cytosis, the severity of this patient's hemolytic anemia,
and the partial alleviation of hemolysis by splenectomy
suggest that this patient is homozygous for a recessive
trait.3'6'8
Patient S
A 23-year-old white male was known to have hereditary spherocytosis
since a chronic anemia was evaluated as a teenager. He had been well
compensated by a reticulocytosis that maintained his hematocrit between
34 and 37%. A positive family history was present, and his father had
undergone splenectomy for the disease. During a bout of infectious
mononucleosis, his hematocrit decreased to 23% and he became icteric.
After recovery, he accepted the recommendation for splenectomy. The
spleen was easily palpable in the left upper quadrant. He had no symptoms
suggestive of recurring biliary colic, and oral cholecystography demon-
strated a normally functioning gallbladder without calculi. Following
splenectomy, his hematocrit rose to 43% and he had significantly more
energy, an improved feeling of well being, and an increased exercise
tolerance.
Comment
Patients with mild hereditary spherocytosis frequently
notice an increase in energy and an improved sense of
well being that is difficult to explain on the basis ofa slight
improvement in their hemoglobin level following sple-
nectomy.
Clinical Material and Results
During the 15-year period from 1970 through 1984,23
patients had splenectomy for hereditary spherocytosis at
the North Carolina Memorial Hospital. The pertinent
clinical data in these patients are displayed in Table 1.
Age at splenectomy ranged from 7 months to 64 years.
Twelve patients were less than 10 years ofage at operation,
and four patients were under 18 months of age. These
latter four patients had transfusion dependent anemia re-
quiring packed red cells every 3 to 6 weeks. There were
13 males and 10 females, reflecting the equal sex incidence
of HS. Twenty-two of our patients were white and one
was black. Splenomegaly was detected by palpation in 22
patients (96%) and was confirmed by splenic weight in all
patients. Splenic weights ranged from 80 to 1025 g with
the average splenic weight increasing with patient age. In
adult patients, the splenic weights were approximately
three to five times normal. Accessory splenic tissue was
identified in nine (39%) of the patients, eight of whom
were children under 10 years of age. An accessory spleen
was present in all four children with transfusion dependent
anemia.
Cholelithiasis was present in six (26%) of our patients
and was demonstrated before operation by either oral
cholecystography or gallbladder ultrasonography. Cho-
lecystectomy was performed at the time of splenectomy
in five patients. One patient had required cholecystectomy
for symptomatic cholelithiasis prior to splenectomy. Our
youngest patient with cholelithiasis (Patient 1) was a 5-
year-old girl with upper abdominal symptoms suggestive
of recurring biliary colic in whom ultrasonography dis-
closed gallbladder sludge.
The immediate postoperative recovery period was re-
markably free ofcomplications for this otherwise healthy
group of patients. One patient undergoing cholecystec-
tomy and common duct exploration at the time of sple-
nectomy was initially felt to have a retained common duct
stone. A subsequent tube cholangiogram, however, dis-
closed a normal biliary tract. Another patient having sple-
nectomy alone developed transient, mild elevation in
serum amylase without other clinical evidence ofpancre-
atitis. Postoperative pneumonia and wound infection did
not occur in this series. The average length of hospital-
ization after operation was 5.6 days.
All patients were significantly benefited by splenectomy
with complete correction ofanemia in the majority. Four
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FIG. 1. In the hypothesized
structure of the erythrocyte
membrane and membrane
skeleton, spectrin dimers are
linked to each other at one
end to form tetramers (long
strands) and are linked into
a network by attachment to
actin (small grouped spheres)
at the other end. The spec-
trin-actin binding is greatly
strengthened by the presence
ofprotein 4.1 (large spheres).
The network is attached to
the lipid membrane via an-
kyrin through linkage to pro-
tein 3 embedded in the lipid
bilayer. Protein 4.1 may also
bind the actin-spectrin com-
plex to the transmembrane
glycoprotein glycophorin.
(Modified from Lux SE and
Shohet SB. The erythrocyte
membrane skeleton: bio-
chemistry. Hosp Pract 1984;
19(10):77-83. Reproduced
and used with permission.)
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patients in whom severe spectrin deficiency has been doc-
umented, Patients 2, 3, and 4 and a 15-month-old male
with transfusion dependent anemia and no family history
of hereditary spherocytosis, were all improved following
splenectomy. Although they no longer require transfusion,
these four patients remain moderately anemic (hemoglo-
bin 10 to 13 g/dl).
Discussion
The clinical presentation of hereditary spherocytosis is
primarily dependent on the severity of hemolysis. Pro-
longed or excessive hyperbilirubinemia in the neonatal
period may be an early manifestation of severe disease.2
In older children and young adults, symptoms ofanemia,
intermittent jaundice, or splenomegaly may lead to eval-
uation and diagnosis. Hereditary spherocytosis resulting
from autosomal dominant inheritance commonly is as-
sociated with a family history of anemia, jaundice, sple-
nectomy, cholelithiasis, and cholecystectomy. A negative
family history is to be expected in patients in whom HS
results from spontaneous mutation or autosomal recessive
inheritance. In those kindreds with autosomal recessive
inheritance, the presumed homozygotes have marked
spherocytosis and severe hemolysis. Heterozygotes are
asymptomatic, and their red cells have a normal shape.3'8
During the past 15 years, research into the structural
organization of the red cell has contributed to a better
understanding ofmany hemolytic anemias. Immediately
beneath the lipid bilayer of the erythrocyte plasma mem-
brane is the membrane skeleton that is thought to be re-
sponsible for the shape, durability, and reversible deform-
ability of the red cell.3-58 The membrane skeleton is
formed by a reticular network ofthree polypeptides, spec-
trin, actin, and protein 4.1.4,5,8 Spectrin, so named because
it was initially extracted from red cell ghosts (spectres), is
the principle structural protein of the membrane skele-
ton.4'5'8 Spectrin is a long, flexible molecule comprised of
two string-like subunits (alpha and beta chains) aligned
in parallel and twisted about each other to form the spec-
trin dimer.4'8 Through head to head association, spectrin
dimers form tetramers and higher oligomers in which di-
mers are joined to form spiderweb-like structures. At their
distal ends, spectrin tetramers bind with actin, an inter-
action that is markedly enhanced by protein 4.1, to con-
nect tetramers and higher oligomers into a two-dimen-
sional network, the membrane skeleton.4'8
In the hypothesized structure of the red cell membrane,
the membrane skeleton is attached to the inner surface
ofthe lipid bilayer by two other proteins (Fig. 1). Ankyrin
binds to spectrin and is itself "anchored" through linkage
to protein 3, an integral protein embedded in the lipid
bilayer.4'5'8 Binding between the actin-protein 4.1 complex
and glycophorin, another integral protein of the lipid bi-
layer, provides another point ofattachment for the mem-
brane skeleton.4'5'8 The elastic, self-supporting membrane
skeleton is thus firmly attached to the lipid membrane
and serves to maintain the shape and structural integrity
ofthe erythrocyte against the stresses ofthe circulation.4'5
Defects of the membrane skeleton due to deficiencies
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TABLE 2. Incidence of Cholelithiasis in Hereditary Spherocytosis
Number Number with Age in Years
of Cholelithiasis
Author/Year Patients (%) <10 >10
Bates and Brown,
1952 93 40 (43) 1 39
Chamberlain, 1962 25 8 (32) NS NS
Krueger and Burgert,
1966 81* 8 (10) 4 4
Barker and Martin,
1969 28 9 (32) NS NS
Lawrie and Ham,
1974 20 11 (55) NS NS
Rutkow, 1981 58 12(21) 1 11
Croometal., 1986 23 6 (26) 2 4
NS = Not stated.
* All children under 15 years of age.
of skeletal proteins or defective association of skeletal
proteins recently have been described in certain hereditary
hemolytic anemias.8 Preeminent among these is hereditary
spherocytosis. The first example of a membrane skeletal
defect producing hemolytic anemia was found in several
strains of the house mouse. In these animals with auto-
somal recessive spherocytosis, the red cells are so fragile
that they spontaneously lose membrane vesicles until the
limiting spherical shape is reached. This extraordinary
red cell fragility results from severe spectrin deficiency.5 8
Several variant strains have been identified in which the
severity of hemolysis correlates closely with the degree of
spectrin deficiency. Furthermore, incorporation ofnormal
mouse spectrin into spectrin deficient red cells results in
a reduction in their osmotic and mechanical fragility and
improvement of their structural integrity.5 8
A human analogue ofthe mouse model has been found
in some inbred kindreds and is illustrated in patients 2
and 3. Both patients had marked spherocytosis and severe
hemolysis with their red cells having less than 50% of the
normal spectrin content.3'6 This rare form of hereditary
spherocytosis resulting from marked spectrin deficiency
is recessively inherited.?35'6
The more common autosomal dominant form of he-
reditary spherocytosis has been found to result from de-
fective binding ofspectrin to protein 4.1.5,8 Using a highly
sensitive radioimmunoassay for spectrin quantitation,
Agre et al. have demonstrated a modest spectrin deficiency
(5 to 20%) in these patients also.5 6 Additionally, the mag-
nitude of the spectrin deficiency has been found to cor-
relate with the severity ofthe disease.6 It is speculated that
a partial deficiency in spectrin results in an underlying
membrane skeleton that cannot support adequately all
regions of the lipid bilayer, leading to loss of small areas
of unsupported lipid and integral membrane proteins.6
Thus far partial spectrin deficiency and defective binding
ofspectrin to protein 4.1 are clearly established membrane
skeletal defects resulting in hereditary spherocytosis in
man. Because of the marked heterogeneity of HS, it is
likely that other defects such as defective binding of the
membrane skeleton to the lipid bilayer may be responsible
for some forms of HS that are not explained by either of
these identified pathophysiologic mechanisms.5' 8
As a result ofthe defect in the membrane skeleton, the
erythrocytes of patients with HS are more fragile and
gradually lose membrane vesicles with resultant loss of
surface area and sphering. These spherocytic red cells are
limited in their ability to deform, and because of their
inability to squeeze through the small pores between en-
dothelial cells of the splenic sinuses to enter the venous
circulation, they are readily trapped in the splenic red
pulp.
Splenectomy is indicated in virtually every patient with
hereditary spherocytosis. When the diagnosis is established
in early childhood, the risk of overwhelming postsple-
nectomy sepsis makes it advisable, if possible, to delay
elective splenectomy until after 6 years of ge. If anemia
is severe enough to require frequent transfusion or if he-
molytic crisis or other associated clinical problems occur,
splenectomy should be performed regardless of the pa-
tient's age. Four ofour patients had transfusion dependent
anemia and required splenectomy before 18 months of
age. Splenectomy with identification and removal of any
accessory splenic tissue is relatively easy in the very young
child. The danger of overwhelming sepsis can be reduced
by penicillin prophylaxis and administration of pneu-
mococcal vaccine after 2 years of age when the child has
become capable of a satisfactory antibody response.
Chronic hemolysis results in an increased development
of pigment gallstones. The incidence of cholelithiasis in
HS ranges from 10% to 55%9-14 (Table 2). The likelihood
of cholelithiasis is directly related to patient age, and cho-
lelithiasis before 10 years of age is uncommon. The in-
cidence of cholelithiasis in adult patients with HS is ap-
proximately 30%, and evaluation of all adult patients by
preoperative gallbladder ultrasonography or oral chole-
cystography seems advisable. Ifcholelithiasis is identified,
cholecystectomy should be performed at the time of sple-
nectomy.
Although spherocytosis persists following splenectomy,
hemolysis is alleviated and clinical cure of the anemia is
achieved for most patients. Patients with recessively in-
herited spherocytosis are exceptions. Although these pa-
tients are significantly benefited by splenectomy, their
anemia is not completely corrected. Splenectomy reduces
hemolysis in all patients and thereby decreases the risk
for development of pigment gallstones. Excision of an
enlarged spleen removes the danger oftraumatic rupture.
Overlooked accessory splenic tissue occasionally results
in recurrence of the hematologic disorder for which sple-
nectomy had been performed. Cases of recurrence of
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hemolysis in hereditary spherocytosis have been re-
ported,'5-'7 and a careful search to identify and remove
any accessory spleens should be done at the time of sple-
nectomy. Accessory splenic tissue was identified in 39%
of our patients, eight of whom were children under 10
years of age. An accessory spleen was present in all four
children with transfusion dependent anemia. This some-
what higher incidence ofaccessory spleens and, in partic-
ular, the presence of accessory splenic tissue in all of our
youngest and most severely affected patients support the
hypothesis that very small nests ofsplenic tissue in patients
with hematologic disease respond to stimulation from the
disease and grow to a clinically detectable size more com-
monly than similar nests ofsplenic tissue in patients with-
out hematologic disease.'8
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